Amanda Mannes - Wellness Coach & Accredited Practising Dietitian

03/08/2026

Six weeks of practical midlife health support—pilot price $80.

02/08/2026

💚 Did you know?

More information can be found here: https://www.mbsonline.gov.au/internet/mbsonline/publishing.nsf/Content/Factsheet-Menopause+and+perimenopause+health+assessment+services

01/08/2026

The Rural Women RISE Program offers an online class option as well.

🔆 This is starting on Wednesday 19 August and reoccurs for 6 weeks. A small online group is available Australia-wide.

💚 To book your spot, visit: https://www.amandamannes.com.au/rise

31/07/2026

🔆 RISE brings together practical expertise from dietitian and menopause coach Amanda Mannes, Dr Julia Spicer from Ally Health and women’s health physiotherapist Claire Lawson.

💚 Together, we’ll help you better understand hormones, nutrition, long-term health and pelvic floor changes - within one supportive group program.

What would you most like to ask our experts?

31/07/2026

Imagine feeling more confident about what is changing in your body and knowing which actions genuinely matter for your future health.

The Coleambally RISE pilot is almost here, and places are limited.
Thanks to support from Murrumbidgee Council and the Country Women’s Association-Coleambally Argoon Branch, the $340 program is available to pilot participants for just $80.
Secure your place at: www.amandamannes.com.au/rise 💚

30/07/2026

RISE focuses on helping you feel better informed, stronger and more confident about your health. We explore energy, muscle, metabolic health, sleep, inflammation, pelvic health and sustainable habits - without restrictive diets or unrealistic promises. This is about supporting your body for the years ahead.

🔆 💚 🔆

29/07/2026

Imagine a future where dietitian can prescribe. Most people that haven’t seen a dietitian don’t realise that we are scientists that are forever leaving how the body works and how food effects it, but to understand that well we also need a good understanding of modes of action of medication of the condition we commonly see. I have help asked many doctors to review patients medications or bloods to consider diagnosis they hadn’t considered, not because the doctor did anything wrong but because as a dietitian, we spend so much longer with clients understanding their symptoms and effects on the body when they are making lifestyle changes. I would love this! I would love to hear your thoughts?

29/07/2026

Across the six weeks, we’ll explore hormones and inflammation, nutrition and hydration, muscle and metabolic health, bone and heart health, pelvic floor changes, sleep, stress, brain fog and sustainable habits.

💚 You’ll finish with a clearer understanding of what your body needs and where to focus first.

Find out more at: www.amandamannes.com.au/rise

08/02/2026

🫛 Homemade Almond Butter = Anti-Inflammatory Power! 🥄

I just whipped up my own almond butter and wow… nothing beats the creamy, nutty goodness of homemade! 💛

Almonds aren’t just tasty—they’re packed with:
✨ Healthy fats to support heart health
✨ Vitamin E & antioxidants that fight inflammation
✨ Magnesium for muscles, bones & relaxation
✨ Protein & fiber to keep you full and balanced

Making it at home means no added sugars or oils, just pure almond goodness. Spread it on some some apple, swirl it in yogurt, or enjoy straight off the spoon (no judgment here 😉).

Your body—and your taste buds—will thank you!

01/12/2025

If you’re taking any weight loss injections, please read this! Please seek help if you need it.

⚠️ Product warnings updated for GLP-1 RA class⚠️

*Content advice – this post contains reference to su***de*

We have updated the product warnings for GLP-1 and dual GIP/GLP-1 receptor agonists for two separate safety issues.

This relatively new and high-profile class of medicines is used to treat type 2 diabetes mellitus and/or obesity.

Medicines in the GLP-1 RA class currently marketed in Australia are:
• Ozempic (semaglutide)
• Wegovy (semaglutide)
• Saxenda (liraglutide)
• Trulicity (dulaglutide)
• Mounjaro (tirzepatide)

1. Potential risk of suicidal thoughts
Product warnings across the GLP-1 RA class of medicines have been aligned to ensure consistent information regarding the potential risk of suicidal thoughts or behaviours.

The updates follow investigations by TGA and other international regulators.

Patients taking any of these medicines should tell their health professional if they experience new or worsening depression, suicidal thoughts or any unusual changes in mood or behaviour.

If you or anyone you know needs help, call Lifeline on 13 11 14.

2. Mounjaro (tirzepatide) and contraception
Our investigation into the potential for reduced effectiveness of oral contraception when first taking or increasing the dose of Mounjaro (tirzepatide) has found that this association could not be ruled out.

As a precautionary measure, the product warnings for tirzepatide have been updated to include further advice for patients using oral contraceptives. Patients taking tirzepatide are advised to switch to a non-oral contraceptive or add a barrier method of contraception for 4 weeks after first taking the medicine and for 4 weeks after each increase in the dose.

None of the GLP-1 RAs should be used during pregnancy and individuals of childbearing potential are advised to use effective contraception during treatment with a GLP-1 RA.

Read more: https://www.tga.gov.au/safety/safety-monitoring-and-information/safety-alerts/product-warnings-updated-glp-1-ra-class